FDA Approves First Drug for Treatment of Tardive Dyskinesia

Ingrezza (valbenazine) capsules approved for treatment of adults with tardive dyskinesia
Source: The Doctors Lounge - Psychiatry - Category: Psychiatry Tags: Family Medicine, Geriatrics, Internal Medicine, Neurology, Nursing, Pharmacy, Psychiatry, Institutional, Source Type: news